3D bioprinting technology innovation in female reproductive system
Source abstract
Abstract
Several diseases affect the female reproductive system, and both disease factors and treatments impact its integrity and function. Consequently, understanding the mechanisms of disease occurrence and exploring treatment methods are key research focuses in obstetrics and gynecology. However, constructing accurate disease models requires a microenvironment closely resembling the human body, and current animal models and 2D in vitro cell models fall short in this regard. Thus, innovative in vitro female reproductive system models are urgently needed. Additionally, female reproductive system diseases often cause tissue loss, yet effective tissue repair and regeneration have long been a bottleneck in the medical field. 3D bioprinting offers a solution by enabling the construction of implants with tissue repair and regeneration capabilities, promoting cell adhesion, extension, and proliferation. This helps maintain the long-term efficacy of bioactive implants and achieves both structural and functional repair of the reproductive system. By combining live cells with biomaterials, 3D bioprinting can create in vitro 3D biomimetic cellular models, facilitating in-depth studies of cell-cell and cell-extracellular microenvironment interactions, which enhances our understanding of reproductive system diseases and supports disease-specific drug screening. This article reviews 3D bioprinting methods and materials applicable to the female reproductive system, discussing their advantages and limitations to aid in selecting optimal 3D bioprinting strategies. We also summarize and critically evaluate recent advancements in 3D bioprinting applications for tissue regeneration and in vitro disease models and address the prospects and challenges for translating 3D bioprinting technology into clinical applications within the female reproductive system.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: 3D Printing in Biomedical Research · Biomedical Ethics and Regulation · Additive Manufacturing and 3D Printing Technologies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Cunningham · 2014
2. Berek · 2011
3. Anatomical causes of female infertility and their management
4. Three-dimensional printing of Hela cells for cervical tumor model in vitro10.1088/1758-5082/6/3/035001 ↗
5. A bioprosthetic ovary created using 3D printed microporous scaffolds restores ovarian function in sterilized mice10.1038/ncomms15261 ↗
6. A three-dimensional in vitro ovarian cancer coculture model using a high-throughput cell patterning platform10.1002/biot.201000340 ↗
7. 3D Bioprinting a human iPSC-derived MSC-loaded scaffold for repair of the uterine endometrium10.1016/j.actbio.2020.09.012 ↗
8. Printing 3D vagina tissue analogues with vagina decellularized extracellular matrix bioink10.1016/j.ijbiomac.2021.03.070 ↗
9. Three-dimensional bioprinting of artificial ovaries by an extrusion-based method using gelatin-methacryloyl bioink10.1080/13697137.2021.1921726 ↗
10. Nano-electrochemical characterization of a 3D bioprinted cervical tumor model10.3390/cancers15041327 ↗
11. Drug-free in vitro activation combined with 3D-bioprinted adipose-derived stem cells restores ovarian function of rats with premature ovarian insufficiency10.1186/s13287-022-03035-3 ↗
12. 3D bioprinted endometrial stem cells on melt electrospun poly ε-caprolactone mesh for pelvic floor application promote anti-inflammatory responses in mice10.1016/j.actbio.2019.08.003 ↗
13. Reproductive biology10.1126/stke.2002.138.eg9 ↗
14. Arch. Reproductive outcome following hysteroscopic adhesiolysis in patients with infertility due to Asherman's syndrome
15. Wong · Curr. Opin. Endocrinol. Diabetes Obes. · 2018 · 25 · 39110.1097/MED.0000000000000447 ↗
16. Research progress of stem cell therapy for endometrial injury
17. Premature ovarian insufficiency: pathogenesis and therapeutic potential of mesenchymal stem cell10.1007/s00109-021-02055-5 ↗
18. Stem cell transplantation improves ovarian function through paracrine mechanisms10.2174/1566523220666200928142333 ↗
19. Current approaches for the treatment of premature ovarian failure with stem cell therapy10.1016/j.biopha.2018.03.056 ↗
20. C.A. A review on biomaterials for ovarian tissue engineering,Amorim10.1016/j.actbio.2021.08.026 ↗
21. The conservation of human functional variants and their effects across livestock species10.1038/s42003-022-03961-1 ↗
22. iTRAQ-based quantitative proteomic comparison of 2D and 3D adipocyte cell models Co-cultured with macrophages using online 2D-nanoLC-ESI-MS/MS
23. Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer10.3892/or.2015.3767 ↗
24. Development of 3D bioprinting: from printing methods to biomedical applications
25. A. A 3D bioprinting system to produce human-scale tissue constructs with structural integrity10.1038/nbt.3413 ↗
26. Current advances and future perspectives in extrusion-based bioprinting10.1016/j.biomaterials.2015.10.076 ↗
27. A brief review of extrusion-based tissue scaffold bio-printing10.1002/biot.201600671 ↗
28. Converging 2D nanomaterials and 3D bioprinting technology: state-of-the-art, challenges, and potential outlook in biomedical applications
29. D bioprinting for biomedical devices and tissue engineering: a review of recent trends and advances
30. Bioscaffolds embedded with regulatory modules for cell growth and tissue formation: a review
31. Bioink properties before, during and after 3D bioprinting10.1088/1758-5090/8/3/032002 ↗
32. Recent advances in bioprinting techniques: approaches, applications and future prospects10.1186/s12967-016-1028-0 ↗
33. Scaffold-free bioprinting of mesenchymal stem cells with the Regenova printer: optimization of printing parameters
34. An introduction to 3D bioprinting: possibilities, challenges and future aspects10.3390/ma11112199 ↗
35. The 3D printing of gelatin methacrylamide cell-laden tissue-engineered constructs with high cell viability10.1016/j.biomaterials.2013.09.078 ↗
36. Gelatin-methacrylamide hydrogels as potential biomaterials for fabrication of tissue-engineered cartilage constructs10.1002/mabi.201200471 ↗
37. Generation of three-dimensional hepatocyte/gelatin structures with rapid prototyping system10.1089/ten.2006.12.83 ↗
38. 3D bioprinting of vascularized, heterogeneous cell-laden tissue constructs10.1002/adma.201305506 ↗
39. Multi-material 3D bioprinting of porous constructs for cartilage regeneration10.1016/j.msec.2019.110578 ↗
40. Demonstration of multi-analyte patterning using piezoelectric inkjet printing of multiple layers10.1016/j.aca.2008.01.048 ↗
41. Microenvironments engineered by inkjet bioprinting spatially direct adult stem cells toward muscle- and bone-like subpopulations10.1634/stemcells.2007-0520 ↗
42. 3D bioprinting of tissues and organs10.1038/nbt.2958 ↗
43. Polymeric systems for bioprinting10.1021/acs.chemrev.9b00834 ↗
44. A review of recent advances in 3D bioprinting with an eye on future regenerative therapies in veterinary medicine10.3389/fvets.2020.584193 ↗
45. 3D bioprinting: improving in vitro models of metastasis with heterogeneous tumor microenvironments10.1242/dmm.025049 ↗
46. Review of bioprinting in regenerative medicine: naturally derived bioinks and stem cells10.1021/acsabm.1c00219 ↗
47. Recent advances in smart biotechnology: hydrogels and nanocarriers for tailored bioactive molecules depot10.1016/j.cis.2017.05.009 ↗
48. Advanced material strategies for next-generation additive manufacturing10.3390/ma11010166 ↗
49. Gelatin as a delivery vehicle for the controlled release of bioactive molecules10.1016/j.jconrel.2005.09.023 ↗
50. Printing cell-laden gelatin constructs by free-form fabrication and enzymatic protein crosslinking10.1007/s10544-014-9915-8 ↗
51. Direct-write bioprinting of cell-laden methacrylated gelatin hydrogels10.1088/1758-5082/6/2/024105 ↗
52. Advanced polymers for three-dimensional (3D) organ bioprinting10.3390/mi10120814 ↗
53. Complex heterogeneous tissue constructs containing multiple cell types prepared by inkjet printing technology10.1016/j.biomaterials.2012.09.035 ↗
54. Alginate: properties and biomedical applications10.1016/j.progpolymsci.2011.06.003 ↗
55. Multicomponent polysaccharide alginate-based bioinks10.1039/D0TB01005G ↗
56. Alginate composites for bone tissue engineering: a review10.1016/j.ijbiomac.2014.07.008 ↗
57. 3D Bioprinting a human iPSC-derived MSC-loaded scaffold for repair of the uterine endometrium10.1016/j.actbio.2020.09.012 ↗
58. 3D bioprinted endometrial stem cells on melt electrospun poly ε-caprolactone mesh for pelvic floor application promote anti-inflammatory responses in mice10.1016/j.actbio.2019.08.003 ↗
59. Fibrinogen and fibrin structure and functions10.1111/j.1538-7836.2005.01365.x ↗
60. Silk fibroin scaffold as a potential choice for female pelvic reconstruction: a study on the biocompatibility in abdominal wall, pelvic, and vagina10.1002/jemt.22653 ↗
61. Silk fibroin scaffold as a potential choice for female pelvic reconstruction: a study on the biocompatibility in abdominal wall, pelvic, and vagina
62. Bioprinting of mineralized constructs utilizing multichannel plotting of a self-setting calcium phosphate cement and a cell-laden bioink10.1088/1758-5090/aad36d ↗
63. Decellularization and antibody staining of mouse tissues to map native extracellular matrix structures in 3D10.1038/s41596-019-0225-8 ↗
64. “Tissue papers” from organ‐specific decellularized extracellular matrice10.1002/adfm.201700992 ↗
65. The decellularized extracellular matrix in regenerative medicine10.2217/rme-2017-0046 ↗
66. Extracellular matrix as a biological scaffold material: structure and function10.1016/j.actbio.2008.09.013 ↗
67. Maintenance of human hepatocyte FunctionIn vitroby liver-derived extracellular matrix gels10.1089/ten.tea.2008.0587 ↗
68. Recent trends in decellularized extracellular matrix bioinks for 3D printing: an updated review10.3390/ijms20184628 ↗
69. Synthetic polymers for organ 3D printing10.3390/polym12081765 ↗
70. Application of 3D biomimetic models in drug delivery and regenerative medicine10.2174/1381612821666150115154059 ↗
71. Optimizing the fabrication processes for manufacturing a hybrid hierarchical polyurethane–cell/hydrogel construct10.1177/0883911513491359 ↗
72. Controlled release of growth factors for regenerative medicine10.2174/1381612821666150115154602 ↗
73. Emerging biomaterials for reproductive medicine10.1016/j.engreg.2021.11.006 ↗
74. The return of a forgotten polymer—polycaprolactone in the 21st century10.1016/j.progpolymsci.2010.04.002 ↗
75. PLGA-based nanoparticles: an overview of biomedical applications10.1016/j.jconrel.2012.01.043 ↗
76. Biomaterial scaffolds for reproductive tissue engineering10.1007/s10439-016-1779-z ↗
77. A. Engineering of vaginal tissuein Vivo,Atala10.1089/107632703764664765 ↗
78. Tissue engineering a complete vaginal replacement from a small biopsy of autologous tissue10.1097/TP.0b013e31817f1686 ↗
79. Stereolithography apparatus and digital light processing-based 3D bioprinting for tissue fabrication10.1016/j.isci.2023.106039 ↗
80. Coaxial bioprinting of cell-laden vascular constructs using a gelatin–tyramine bioink10.1039/C8BM00618K ↗
81. Tissue engineering and regenerative medicine: history, progress, and challenges10.1146/annurev-chembioeng-061010-114257 ↗
82. 3D printing in regenerative medicine: technologies and Resources utilized10.3390/ijms232314621 ↗
83. A comprehensive review of Asherman's syndrome: causes, symptoms and treatment options10.1097/GCO.0000000000000378 ↗
84. Principles of regenerative medicine and their application in the female reproductive system,Opara10.1016/j.maturitas.2013.10.007 ↗
85. Bioengineering trends in female reproduction: a systematic review10.1093/humupd/dmac025 ↗
86. Microphysiological modeling of the reproductive tract: a fertile endeavor10.1177/1535370214529387 ↗
87. Premature ovarian failure]. Insuffisance ovarienne prematuree,J. Gynecol
88. Ovarian tissue and oocyte cryopreservation prior to iatrogenic premature ovarian insufficiency10.1016/j.bpobgyn.2021.09.010 ↗
89. Genetics of premature ovarian insufficiency and the association with X-autosome translocations10.1530/REP-20-0338 ↗
90. Fertility preservation: the challenge of freezing and transplanting ovarian tissue10.1016/j.molmed.2020.11.003 ↗
91. Fertility preservation: freezing of ovarian tissue and clinical opportunities10.1530/REP-18-0635 ↗
92. Spatial analysis of growing follicles in the human ovary to inform tissue engineering strategies10.1089/ten.tea.2020.0051 ↗
93. Bioengineering the ovarian follicle microenvironment10.1146/annurev-bioeng-071813-105131 ↗
94. Premature ovarian failure and tissue engineering10.1002/jcp.29376 ↗
95. Fertility preservation: how to preserve ovarian function in children, adolescents and adults10.3390/jcm10225247 ↗
96. A review of 3D printing techniques and the future in biofabrication of bioprinted tissue10.1007/s12013-016-0730-0 ↗
97. Cyclic decidualization of the human endometrium in reproductive health and failure10.1210/er.2014-1045 ↗
98. Histological 3D reconstruction and in vivo lineage tracing of the human endometrium10.1002/path.5478 ↗
99. Three-dimensional understanding of the morphological complexity of the human uterine endometrium10.1016/j.isci.2021.102258 ↗
100. The role of mesenchymal-epithelial transition in endometrial function10.1093/humupd/dmy035 ↗